Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT

Bone Marrow Transplantation

Volumn 48, Issue 5, 2013, Pages 703-707

  Holm, A M ^a,b   Riise, G C ^c   Hansson, L ^d   Brinch, L ^a   Bjortuft ^a   Iversen, M ^e   Simonsen, S ^a   Floisand Y ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e Rigshospitalet   (Denmark)

Author keywords

allo SCT; lung transplantation; survival

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; DACLIZUMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BACTERIAL COLONIZATION; BRONCHIOLITIS OBLITERANS; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DENMARK; DRUG MEGADOSE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPLANT REGISTRY; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; NORWAY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RECURRENT DISEASE; SCHOOL CHILD; SEPTICEMIA; STENOTROPHOMONAS MALTOPHILIA; SURVIVAL RATE; SWEDEN;

ADOLESCENT; ADULT; BRONCHIOLITIS OBLITERANS; CHILD; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; SCANDINAVIA; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84877649542     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.197     Document Type: Article

References (19)

1. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956.
2. Baird K, Pavletic SZ. Chronic graft versus host disease. Curr Op Hematol 2006; 13: 426-435.
3. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant 2012; 47: 337-341.
4. Sakaida E, Nakaseko C, Harima A, Yokota A, Cho R, Saito Y et al. Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect. Blood 2003; 102: 4236-4242.
5. Lund MB, Brinch L, Kongerud J, Boe J. Lung function 5 yrs after allogeneic bone marrow transplantation conditioned with busulphan and cyclophosphamide. Eur Resp J 2004; 23: 901-905.
6. Vos R, Vanaudenaerde BM, Ottevaere A, Verleden SE, De Vleeschauwer SI, Willems-Widyastuti A et al. Long-term azithromycin therapy for bronchiolitis obliterans syndrome: Divide and conquer? J Heart Lung Transplant 2010; 29: 1358-1368.
7. Chien JW, Duncan S, Williams KM, Pavletic SZ. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2010; 16(1 Suppl): S106-S114.
8. Martin PJ, Chien JW. What we know and mostly do not know about bronchiolitis obliterans syndrome. Bone Marrow Transplant 2012; 47: 1-4.
9. Lucid CE, Savani BN, Engelhardt BG, Shah P, Clifton C, Greenhut SL et al. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT. Bone Marrow Transplant 2011; 46: 426-429.
10. Redel-Montero J, Bujalance-Cabrera C, Vaquero-Barrios J-M, Santos-Luna F, Arenas-De Larriva M, Moreno-Casado P et al. Lung transplantation for bronchiolitis obliterans after allogenic bone marrow transplantation. Transplant Proc 2010; 42: 3023-3025.
11. Rabitsch W, Deviatko E, Keil F, Herold C, Dekan G, Greinix HT et al. Successful lung transplantation for bronchiolitis obliterans after allogeneic marrow transplantation. Transplantation 2001; 71: 1341-1343.
12. Whitson BA, Shelstad RC, Hertz MI, Kelly RF, D'aposCunha J, Shumway SJ. Lung transplantation after hematopoietic stem cell transplantation. Clin Transplant 2012; 26: 254-258.
13. Chiang KY, Lazarus HM. Should we be performing more combined hematopoietic stem cell plus solid organ transplants? Bone Marrow Transplant 2003; 31: 633-642.
14. Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dobbels F, Kirk R et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report-2011. J Heart Lung Transplant 2011; 30: 1104-1122.
15. Koenecke C, Hertenstein B, Schetelig J, Van Biezen A, Dammann E, Gratwohl A et al. Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMT. Am J Transplant 2010; 10: 1897-1906.
16. Orens J, Estenne M, Arcasoy S, Conte J, Corris P, Egan J et al. International guidelines for the selection of lung transplant candidates: 2006 updatea consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25: 745-755.
17. Ustun C, Miller JS, Munn DH, Weisdorf DJ, Blazar BR. Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation? Blood 2011; 118: 5084-5095.
18. Palmer SM, Limaye AP, Banks M, Gallup D, Chapman J, Lawrence EC et al. Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial. Ann Intern Med 2010; 152: 761-769.
19. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15: 1143-1238.